Home > Cashflow Statement > BIOCON

BIOCON
Cash Flow from Operating Activities

    Back to Cashflow Statement
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

BIOCON Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹4,061 Cr₹2,954 Cr₹1,853 Cr₹1,177 Cr₹1,160 Cr

What is the latest Cash Flow from Operating Activities ratio of BIOCON ?

The latest Cash Flow from Operating Activities ratio of BIOCON is ₹4,061 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹4,061 Cr
Mar2024₹2,954 Cr
Mar2023₹1,853 Cr
Mar2022₹1,177 Cr
Mar2021₹1,160 Cr

How is Cash Flow from Operating Activities of BIOCON Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹4,061 Cr
37.49
Mar2024 ₹2,954 Cr
59.45
Mar2023 ₹1,853 Cr
57.45
Mar2022 ₹1,177 Cr
1.46
Mar2021 ₹1,160 Cr -

Compare Cash Flow from Operating Activities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹59,195.3 Cr -1.5% -5.7% -0.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-1.5%

-5.7%

-0.8%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses